News

Nestmedic S.A. 14 October 2022, has received notification that the Company’s product, Pregnabit Pro, was registered with the Medicines and Healthcare products Regulatory Agency in London _MHRA_ on 12 October 2022.

The MHRA is the enforcement agency of the Department of Health and Social Care in the UK, which is responsible for ensuring that medicines and medical devices work and are safe.

Based on the product’s registration with the MHRA, the Company can begin the process of distributing Pregnabit Pro medical devices in the UK.

An amazing trade fair and huge potential for the development of home healthcare. A meeting with the Ministry of Health Saudi Arabia is behind us. Together with Al-Dawaa Medical Services Co. we want to tap into the enormous development potential of the region.

Our CEO Jacek Gnich with Sales Director Mateusz Robaczewski presenting Pregnabit Pro in Riyadh

On October 9- 11, 2022, our CEO  Jacek Gnich and Sales Director Mateusz Robaczewski will be present at the Global Health Exhibition in Riyadh.

The Public Health conference is a unique opportunity to discover and discuss current topics in public health research and practice, including chronic disease prevention, epidemics, and the management of health crises.

If you would like to talk about PregnabitPro® and tele CTG, please contact us via Linkedin or email jacek.gnich@nestmedic.com ; mateusz.robaczewski@nestmedic.com